Among patients with serous adenocarcinoma, 5-year survival was 61% and 31% for patients who did and did not undergo lymphadenectomy, respectively(P<0.01).
卵巢浆液性癌,行与未行腹膜后淋巴结切除术患者的5年生存率分别为61%、3 1% (P<0 0 1)。
The 3 year survival rate for radical resection group was 61 1% and higher than that of 18 2% for palliative excision group( P< 0 01).
根治手术病例3年生存率为6 1 1% ,姑息手术病例3年生存率为18 2 % ,两组比较差异有非常显著性意义(P< 0 0 1)。
The 3 year survival rate for radical resection group was 61 1% and higher than that of 18 2% for palliative excision group( P< 0 01).
根治手术病例3年生存率为6 1 1% ,姑息手术病例3年生存率为18 2 % ,两组比较差异有非常显著性意义(P< 0 0 1)。
应用推荐